Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Post

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
HIV Medicine|November 20, 2020
Healthcare delivery for HIV-positive people with tuberculosis in EuropeA K Bentzon, A Panteleev, V Mitsura, et al.
HIV Medicine|December 17, 2011
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011D Asboe, C Aitken, M Boffito, et al.
Archives of Dermatological Research|March 25, 2023
Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey studyNicoline F Post, Noah X Van Broekhoven, Annelies Lommerts, et al.
Journal of the American Academy of Dermatology|March 26, 2023
Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi studyNicoline F Post, Michelle A Rodrigues, Cyetta Liong-A-Jin, et al.
Nature|August 15, 2003
Genome divergence in two Prochlorococcus ecotypes reflects oceanic niche differentiationGabrielle Rocap, Frank W Larimer, Jane Lamerdin, et al.
Allergy|March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccinationAnika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
BMC Medicine|March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseasesLuuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases|May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activityKoos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
Annals of the Rheumatic Diseases|January 31, 2023
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseasesLuuk Wieske, Eileen W Stalman, P J Koos van Dam, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
HIV Medicine|November 20, 2020
Healthcare delivery for HIV-positive people with tuberculosis in EuropeA K Bentzon, A Panteleev, V Mitsura, et al.
HIV Medicine|December 17, 2011
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011D Asboe, C Aitken, M Boffito, et al.
Archives of Dermatological Research|March 25, 2023
Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey studyNicoline F Post, Noah X Van Broekhoven, Annelies Lommerts, et al.
Journal of the American Academy of Dermatology|March 26, 2023
Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi studyNicoline F Post, Michelle A Rodrigues, Cyetta Liong-A-Jin, et al.
Nature|August 15, 2003
Genome divergence in two Prochlorococcus ecotypes reflects oceanic niche differentiationGabrielle Rocap, Frank W Larimer, Jane Lamerdin, et al.
Allergy|March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccinationAnika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
BMC Medicine|March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseasesLuuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases|May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activityKoos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
Annals of the Rheumatic Diseases|January 31, 2023
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseasesLuuk Wieske, Eileen W Stalman, P J Koos van Dam, et al.
Pageof 17